United States Cancer Gene Therapy Market 2018 Analysis By Top Manufacturers: Cell Genesys, Advantagene, GenVec and more.

In this report, the United States Cancer Gene Therapy market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cancer Gene Therapy in these regions, from 2013 to 2025 (forecast).
United States Cancer Gene Therapy market competition by top manufacturers/players, with Cancer Gene Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Adaptimmune
GlaxoSmithKline
Bluebird bio
Merck
Celgene
Shanghai Sunway Biotech
BioCancell
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
OncoGenex Pharmaceuticals
Genelux Corporation
Cell Genesys
Advantagene
GenVec
BioCancell
Celgene
Epeius Biotechnologies
Introgen Therapeutics
Ziopharm Oncology
Shenzhen SiBiono GeneTech
Altor Bioscience
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Diagnostics Centers
Research Institutes
Table of Contents
United States Cancer Gene Therapy Market Report 2018
1 Cancer Gene Therapy Overview
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Classification of Cancer Gene Therapy by Product Category
1.2.1 United States Cancer Gene Therapy Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Cancer Gene Therapy Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Gene Induced Immunotherapy
1.2.4 Oncolytic Virotherapy
1.2.5 Gene Transfer
1.3 United States Cancer Gene Therapy Market by Application/End Users
1.3.1 United States Cancer Gene Therapy Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 United States Cancer Gene Therapy Market by Region
1.4.1 United States Cancer Gene Therapy Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Cancer Gene Therapy Status and Prospect (2013-2025)
1.4.3 Southwest Cancer Gene Therapy Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Cancer Gene Therapy Status and Prospect (2013-2025)
1.4.5 New England Cancer Gene Therapy Status and Prospect (2013-2025)
1.4.6 The South Cancer Gene Therapy Status and Prospect (2013-2025)
1.4.7 The Midwest Cancer Gene Therapy Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Cancer Gene Therapy (2013-2025)
1.5.1 United States Cancer Gene Therapy Sales and Growth Rate (2013-2025)
1.5.2 United States Cancer Gene Therapy Revenue and Growth Rate (2013-2025)
2 United States Cancer Gene Therapy Market Competition by Players/Suppliers
2.1 United States Cancer Gene Therapy Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Cancer Gene Therapy Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Cancer Gene Therapy Average Price by Players/Suppliers (2013-2018)
2.4 United States Cancer Gene Therapy Market Competitive Situation and Trends
2.4.1 United States Cancer Gene Therapy Market Concentration Rate
2.4.2 United States Cancer Gene Therapy Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cancer Gene Therapy Manufacturing Base Distribution, Sales Area, Product Type
3 United States Cancer Gene Therapy Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Cancer Gene Therapy Sales and Market Share by Region (2013-2018)
3.2 United States Cancer Gene Therapy Revenue and Market Share by Region (2013-2018)
3.3 United States Cancer Gene Therapy Price by Region (2013-2018)
4 United States Cancer Gene Therapy Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Cancer Gene Therapy Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Cancer Gene Therapy Revenue and Market Share by Type (2013-2018)
4.3 United States Cancer Gene Therapy Price by Type (2013-2018)
4.4 United States Cancer Gene Therapy Sales Growth Rate by Type (2013-2018)
5 United States Cancer Gene Therapy Sales (Volume) by Application (2013-2018)
5.1 United States Cancer Gene Therapy Sales and Market Share by Application (2013-2018)
5.2 United States Cancer Gene Therapy Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

Comments

Popular posts from this blog

Philippines Meat Substitutes Market Size, Share and Forecast 2018-2025

China Ketchup Market Details Analysis By top Key Players: Nestle, ConAgra Foods, Del Monte and more.

Asia-Pacific Buttermilk Market-Industry Size, Growth, Analysis, Forecast of 2023 and Top Manufacturers Amul, Arla Foods, DairyAmerica and more.